SCHEMBL7564504

SCHEMBL7564504

CN(C)C(=O)c1c(C(=O)N/N=C/c2ccc3ccccc3c2)[nH]c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.54
ESR1 P03372 1/20 0.49
ESRRG P62508 1/20 0.49
ESR2 Q92731 1/20 0.49
ALDH1A1 P00352 5/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
LMNA P02545 3/20 0.45
THRB P10828 2/20 0.45
MGAM O43451 4/20 0.45
GAA P10253 4/20 0.45
SI P14410 4/20 0.45
MGAM2 Q2M2H8 4/20 0.45
DNM1 Q05193 1/20 0.45
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
KDM4E B2RXH2 4/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7564509 1.00 FAAH (0.54) FAAHESR1ESRRGESR2ALDH1A1
SCHEMBL7530021 0.85 MAPT (0.59) FAAHALDH1A1POLBMAPTSMN1; SMN2
SCHEMBL7566498 0.85 MAPT (0.59) FAAHALDH1A1POLBMAPTSMN1; SMN2
SCHEMBL7671082 0.80 FAAH (0.55) FAAHESR1ESRRGESR2ALDH1A1
SCHEMBL7671089 0.80 FAAH (0.55) FAAHESR1ESRRGESR2ALDH1A1
SCHEMBL7672497 0.75 KMT2A (0.56) FAAHESRRGALDH1A1POLBMAPT
SCHEMBL7531206 0.75 KMT2A (0.56) FAAHESRRGALDH1A1POLBMAPT
SCHEMBL7533729 0.72 GAA (0.56) ALDH1A1MAPTSMN1; SMN2LMNAGAA
SCHEMBL13569020 0.71 ESR1 (0.89) FAAHESR1ESRRGESR2POLB
SCHEMBL7567167 0.70 MAPT (0.51) FAAHALDH1A1POLBMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US claimed
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 FAAH 1352/4885ESR1 4274/4885ESRRG 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.